Depressive Disorders - Serbia

  • Serbia
  • Revenue in the Depressive Disorders market is projected to reach US$14.96m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.77%, resulting in a market volume of US$16.33m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
  • In relation to total population figures, per person revenues of US$54.40 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Depressive Disorders market in Serbia is experiencing significant growth due to various factors such as increasing awareness about mental health, changing societal attitudes towards mental illness, and advancements in treatment options.

Customer preferences:
In Serbia, there is a growing preference for seeking professional help for mental health issues, including depressive disorders. This shift in customer preferences can be attributed to the increasing awareness campaigns and educational initiatives that have been implemented to reduce the stigma associated with mental illness. As a result, more individuals are willing to seek treatment and are actively seeking out healthcare professionals specializing in mental health.

Trends in the market:
One of the key trends in the Depressive Disorders market in Serbia is the rising demand for psychotherapy and counseling services. This trend can be attributed to the recognition of the importance of psychological interventions in managing depressive disorders. Additionally, there has been an increase in the availability of qualified mental health professionals, which has further fueled the demand for these services.Another trend in the market is the growing adoption of pharmacological interventions for the treatment of depressive disorders. There has been a significant increase in the prescription of antidepressant medications, as healthcare professionals are becoming more proficient in diagnosing and treating depressive disorders. This trend is also supported by the availability of a wider range of antidepressant drugs in the market.

Local special circumstances:
Serbia has a high prevalence of depressive disorders, which contributes to the growth of the market. This can be attributed to various factors such as social and economic challenges, political instability, and a history of conflict. These circumstances have had a significant impact on the mental health of the population, leading to a higher demand for treatment options.

Underlying macroeconomic factors:
The economic growth in Serbia has had a positive impact on the Depressive Disorders market. As the country's economy continues to develop, there is an increase in disposable income, which allows individuals to afford healthcare services and medications. Additionally, the government has been investing in the healthcare sector, including mental health services, which has further contributed to the growth of the market.In conclusion, the Depressive Disorders market in Serbia is witnessing growth due to changing customer preferences, increasing demand for psychotherapy and counseling services, and the availability of a wider range of treatment options. The local special circumstances, such as a high prevalence of depressive disorders, and the underlying macroeconomic factors, including economic growth and government investments, also play a significant role in the development of the market.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)